http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106220570-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-90 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 |
filingDate | 2016-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106220570-B |
titleOfInvention | Imidazole dehydroabietylamine amide compounds and preparation method and application thereof |
abstract | The invention discloses an imidazole dehydroabietylamine amide compound and a preparation method and application thereof. The compound is 1-methyl-imidazole-5-carboxy-4-acyl-dehydroabietylamine or 1-methyl-imidazole-4,5-diacyl-dehydroabietylamine. The imidazole dehydroabietyl amide compound of the invention expands the types of dehydroabietyl amide compounds, and creates conditions for studying the relationship between the structure and performance of the dehydroabietyl amide compound. At the same time, the imidazole dehydroabietylamine amide compound exhibits good anticancer activity. To provide basis for the development of new anti-cervical cancer and breast cancer drugs. The preparation method of the imidazole dehydroabietylamine amide compound is easy to operate, and the required items in the method are less toxic, combined with natural products, and have good practicability. |
priorityDate | 2016-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 112.